Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 25 EP applications Carolin Townsend has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 29, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11776153

MURINE MODEL OF INFLAMMATION WITH IL33 N-TERMINAL DOMAIN DELETION

IPC classification:
C12N 15/85, A01K 67/027
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP11773470

METHOD OF DETERMINING RISK OF ARRYTHMIA

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP11778773

TREATMENT OF GASTROINTESTINAL INFLAMMATION AND PSORIASIS A

IPC classification:
A61P 37/02, A61K 38/20, A01K 67/027, C07K 16/28, G01N 33/53
Applicant:
Genentech, Inc.
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
APPLICATION WITHDRAWN
EP12726092

METHOD FOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO VASCULAR BED CELLS

IPC classification:
C12N 5/078
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12807315

USE OF ANTI-CD83 AGONIST ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES

IPC classification:
A61K 39/395, C07K 16/28, A61P 37/00
Applicant:
Genentech, Inc.
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12753879

INHIBITION OF ANGIOGENESIS IN REFRACTORY TUMORS

IPC classification:
C07K 16/24, C07K 16/22, A61P 35/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12748488

FC-FREE ANTIBODIES COMPRISING TWO FAB FRAGMENTS AND METHODS OF USE

IPC classification:
C07K 16/30, A61P 35/00
Applicant:
Roche Glycart AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12748490

BISPECIFIC ANTIBODIES SPECIFIC FOR T-CELL ACTIVATING ANTIGENS AND A TUMOR ANTIGEN AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/30, A61P 35/00
Applicant:
Roche Glycart AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP12766549

METHODS OF PROMOTING DIFFERENTIATION

IPC classification:
G01N 33/50
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12845437

OVERLOAD AND ELUTE CHROMATOGRAPHY

IPC classification:
B01D 15/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP12779061

IN VIVO ADCC MODEL

IPC classification:
A01K 67/027, C12N 15/85, C07K 16/28, C07K 14/705
Applicant:
Roche Glycart AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13701252

CHITOSAN COVALENTLY LINKED WITH SMALL MOLECULE INTEGRIN ANTAGONIST FOR TARGETED DELIVERY

IPC classification:
A61K 47/48, A61P 35/00, A61P 29/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13701435

INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING VLA-4

IPC classification:
A61K 47/48, A61P 35/00, A61P 29/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12765884

METHODS OF ADMINISTERING BETA7 INTEGRIN ANTAGONISTS

IPC classification:
A61K 39/395, A61K 39/00, A61K 31/52, A61K 31/519, A61K 31/196, C07K 16/28, C07K 16/00, A61P 1/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12871585

ENGINEERED CONFORMATIONALLY-STABILIZED PROTEINS

IPC classification:
A61K 38/16, G01N 33/68, C07K 14/00, A61P 35/00
Applicant:
F. Hoffmann-La Roche SA
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13707618

METHOD OF DETERMINING TERATOGENIC RISK

IPC classification:
G01N 33/50, C12N 5/0735, C12N 5/071
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13720203

CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION

IPC classification:
C12N 5/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13794597

SELECTION METHOD FOR THERAPEUTIC AGENTS

IPC classification:
G01N 33/58, G01N 33/53, C07K 16/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13773229

FC-FREE ANTIBODIES COMPRISING TWO FAB-FRAGMENTS AND METHODS OF USE

IPC classification:
C07K 16/46, C07K 16/30, C07K 16/28
Applicant:
Roche Glycart AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14708212

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

IPC classification:
C07K 16/32, A61P 35/00, C07K 16/46, C07K 16/28, C07K 16/30
Applicant:
Roche Glycart AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14714275

BISPECIFIC ANTIBODIES SPECIFIC FOR FAP AND DR5, ANTIBODIES SPECIFIC FOR DR5 AND METHODS OF USE

IPC classification:
A61P 35/00, A61K 39/395, C07K 16/46, C07K 16/30, C07K 16/40, C07K 16/28
Applicant:
Roche Glycart AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14744087

METHOD FOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO MULTI-COMPETENT RENAL PRECURSORS

IPC classification:
C12N 5/071
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11791737

ANTIBODY BLOCKING THE INTERACTION BETWEEN IGFL1 AND TMEM149

IPC classification:
C07K 16/28, C07K 16/22, C07K 14/705, C07K 14/65
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14821603

BISPECIFIC HER2 ANTIBODIES AND METHODS OF USE

IPC classification:
C07K 16/32
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP17157670

OVERLOAD AND ELUTE CHROMATOGRAPHY

IPC classification:
B01D 15/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carolin Townsend, F. Hoffmann-La Roche AG
Status:
The application has been published

Please Sign in to use this feature